Recently, Chua et al. genetically engineered EcN to produce and secrete interferon lambda 1 (IFNL1) by sensing NO which exhibited anti-inflammatory effects in an in vitro IBD model [150]. This evidence concerns the gene IFNL1 and inflammatory bowel disease.